AJAP1 and hepatocellular carcinoma: It was also observed that miR‐552 targeted AJAP1. By inhibiting AJAP1, miR‐552 promoted HCC cell proliferation, migration and invasion in vitro by regulating EMT and stimulated tumour growth in in vivo.